UNITED STATES

 

SECURITIES AND EXCHANGE COMMISSION

 

WASHINGTON, D.C. 20549

 

----------------------------------------------

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report February 5, 2008

(Date of earliest event reported)

 

Commission File Number 0-16211

 

DENTSPLY INTERNATIONAL INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware

39-1434669

 

(State of Incorporation)

(IRS Employer Identification No.)

 

 

 

 

 

 

 

221 West Philadelphia Street,

 

York, Pennsylvania

17405-0872

(Address of principal executive offices)

(Zip Code)

 

 

 

 

 

 

 

 

Registrant's telephone number, including area code:

(717) 845-7511

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

_____ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

_____ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

_____ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

_____ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

 

 

 

Item 2.02. - Results of Operations and Financial Condition

 

The following information is furnished pursuant to Item 2.02, "Results of Operations and Financial Condition."

 

On February 5, 2008, the Company issued a press release disclosing its fourth quarter and full year 2007 sales and earnings. This earnings release references net sales, excluding precious metal content, and net income, excluding certain unusual items, both of which could be considered measures not calculated in accordance with generally accepted accounting principles (non-GAAP measures). Due to the fluctuations of precious metal prices and because the precious metal content of the Company's sales is largely a pass-through to customers and has minimal effect on earnings, the Company reports sales both with and without precious metal content to show the Company's performance independent of precious metal price volatility and to enhance comparability of performance between periods. Earnings from continuing operations, excluding certain unusual items, is presented to enhance the comparability between periods. A copy of the Company's press release is attached hereto as Exhibit (99.1) and is hereby incorporated by reference.

 

Item 9.01. Financial Statements and Exhibits

 

(a) Financial Statements - Not applicable.

 

(b) Exhibits:

 

99.1 The Dentsply International Inc. fourth quarter and full year 2007 earnings release issued February 5, 2008 as referenced in Item 2.02.

 

 

 

 

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

DENTSPLY INTERNATIONAL INC

(Company)

 

 

/s/

William R. Jellison

William R. Jellison

Senior Vice President and

Chief Financial Officer

 

Date: Feburary 5, 2008

 

 

 

 

 

 

 

NEWS

 

For Further

Information Contact:

 

William R. Jellison

FOR IMMEDIATE RELEASE

Senior Vice President and

Chief Financial Officer

(717) 849-4243

 

DENTSPLY International Inc.

Reports Record Fourth Quarter and

Full Year 2007 Sales and Earnings

 

Annual Sales Cross $2 Billion Milestone

 

York, PA – February 5, 2008 -- DENTSPLY International Inc. (NASDAQ–XRAY) today announced record sales and earnings for the three months and year ended December 31, 2007.

 

FINANCIAL RESULTS

 

Three Months Ended December 31, 2007

 

Net sales in the fourth quarter of 2007 increased 14.9% to $541.5 million compared to $471.3 million reported in the fourth quarter of 2006. Net sales, excluding precious metal content, increased 16.1% in the fourth quarter of 2007. Sales of specialty products, including implants, endodontics, and orthodontic products enjoyed double-digit sales growth in the quarter. Sales growth reflects the impact of improved organic growth, the benefit of acquisitions completed in 2007, and additional exchange impact associated with the weaker US dollar.

 

Net income for the fourth quarter of 2007 was $70.0 million, or $0.45 per diluted share, compared to a net income of $64.9 million, or $0.42 per diluted share, in the fourth quarter of 2006. Net income in the fourth quarter of 2007 includes charges, net of tax, for restructuring and other related items of $1.0 million, ($0.01) per diluted share. The fourth quarter of 2007 also includes a net reduction to income tax expense of $2.5 million, $0.02 per diluted share, from the resolution of certain tax matters. The fourth quarter of 2006 included charges, net of tax, for restructuring and other related items of $1.0 million, ($0.01) per diluted share, and a net reduction of income tax expense of $8.8 million, $0.06 per diluted share, related to the resolution of certain tax matters

 

On an adjusted basis, earnings, excluding restructuring and other related items and tax adjustments, which constitute a non-GAAP measure, were $68.5 million or $0.44 per diluted share in the fourth quarter of 2007, compared to $57.1 million or $0.37 per diluted share in the fourth quarter of 2006, an increase of 18.9% in earnings per diluted share. For a reconciliation of this non-GAAP measure to earnings per share calculated according to GAAP, see the attached table.

 

 

 

 

Year Ended December 31, 2007

 

Sales hit a new milestone in 2007, exceeding $2 billion for the first time. Sales increased 11.0% to $2,009.8 million compared to $1,810.5 million in 2006. Sales, excluding precious metals, increased 12.1% for the year.

 

Net income for 2007 was $259.7 million, or $1.68 per diluted share, compared to $223.7 million or $1.41 per diluted share in 2006. This represents a 19.1% increase in diluted earnings per share.

 

The 2007 earnings of $259.7 million, or $1.68 per diluted share included the following items:

 

1.

Restructuring and other related expenses of $10.5 million ($6.7 million after-tax) or ($0.04) per diluted share.

2.

Net reduction of income tax expense of $9.9 million $0.06 per diluted share related to changes in statutory tax rates in Germany and the favorable resolution of certain tax matters.

 

The 2006 earnings of $223.7 million, or $1.41 per diluted share, included the following items:

 

1.

Restructuring and other related expenses of $7.8 million ($5.0 million after-tax) or ($0.03) per diluted share.

2.

Net reduction of income tax expense of $4.8 million $0.03 per diluted share related to the resolution of certain tax matters.

 

For comparability analysis, net income, excluding restructuring and other related items and tax adjustments for the years ending 2007 and 2006 (a non-GAAP measure), was $256.4 million or $1.66 per diluted share for 2007, compared to $224.0 million or $1.42 per diluted share in 2006, an increase of 16.9% in diluted earnings per share. A reconciliation of this non-GAAP measure to earnings per share calculated according to GAAP is provided in the attached table.

 

 

2007 Results & 2008 Outlook

 

Bret Wise, Chairman and Chief Executive Officer, commented, “We are pleased with the acceleration of our sales growth and earnings performance in 2007, as many of the strategic initiatives implemented in 2006 and 2007 began to contribute to results. During the year, we achieved an important milestone with sales exceeding $2 billion for the first time, just six years after first reaching $1 billion in sales. Our broad product portfolio, focus on consumables, and global footprint position us well for future success. Despite the volatility in the broader global markets, we remain confident in our ability to grow and experience another year of solid performance in 2008. For full year 2008, we believe that internal sales growth will range from 5.5% - 6.5% and total sales growth should approach or exceed 10% as we continue to benefit from acquisitions and current foreign exchange rates. We also anticipate earnings for 2008 to be in the range of $1.83 to $1.88 per diluted share.”

 

 

 

 

ADDITIONAL INFORMATION

 

A conference call has been scheduled for Wednesday, February 6, 2008 at 8:30 AM Eastern Time. A live broadcast is available through Shareholder.com by accessing DENTSPLY’s website at www.dentsply.com. The Conference ID # is 7468500. In order to participate in the call, dial (888) 259-8552 (for domestic calls) and (913) 312-0838 (for international calls). At that time, you will be able to discuss the Fourth Quarter Earnings with DENTSPLY’s Management.

 

An on-line rebroadcast, as well as a transcript of the conference call will be available to the public following the conference call at the DENTSPLY website: www.dentsply.com. A replay will be available for one week following the conference call at (888) 203-1112 (for domestic calls) and (719) 457-0820 (for international calls), Passcode # 7468500.

 

DENTSPLY designs, develops, manufactures and markets a broad range of products for the dental market. The Company believes that it is the world’s leading manufacturer and distributor of dental prosthetics, precious metal dental alloys, dental ceramics, endodontic instruments and materials, prophylaxis paste, dental sealants, ultrasonic scalers, and crown and bridge materials; the leading United States manufacturer and distributor of dental handpieces, dental x-ray film holders, film mounts and bone substitute/grafting materials; and a leading worldwide manufacturer or distributor of dental implants, impression materials, orthodontic appliances, dental cutting instruments, infection control products, and dental injectable anesthetics. The Company distributes its dental products in over 120 countries under some of the most well-established brand names in the industry.

 

DENTSPLY is committed to the development of innovative, high quality, cost-effective new products for the dental market.

 

This press release contains forward-looking information (within the meaning of the Private Securities Litigation Reform Act of 1995) regarding future events or the future financial performance of the Company that involve substantial risks and uncertainties. Actual events or results may differ materially from those in the projections or other forward-looking information set forth herein as a result of certain risk factors.

 

These risk factors include, without limitation; the continued strength of dental markets, the timing, success and market reception for our new and existing products, uncertainty with respect to governmental actions with respect to dental products, outcome of litigation, continued support of our products by influential dental professionals, and changes in the general economic environment that could affect our business. Changes in such assumptions or factors could produce significantly different results.

 

For an additional description of risk factors, please refer to the Company’s Annual Report on Form 10-K and its subsequent periodic reports on Forms 10-Q filed with the Securities and Exchange Commission.

 

Non-GAAP Financial Measures

 

DENTSPLY believes that the non-GAAP financial information provided in this release may be useful to investors for comparison purposes because the Company has historically provided similar information. The non-GAAP financial information should not be considered in isolation from, or as a substitute for, measures of financial performance prepared in accordance with GAAP.

 

 

 

 

DENTSPLY INTERNATIONAL INC.

CONSOLIDATED STATEMENTS OF INCOME

(IN THOUSANDS EXCEPT PER SHARE DATA)

 

 

 

 

 

 

 

 

 

 

 

THREE MONTHS ENDED

 

TWELVE MONTHS ENDED

 

 

DECEMBER 31,

 

DECEMBER 31,

 

 

2007

 

2006

 

2007

 

2006

 

 

 

 

 

 

 

 

 

NET SALES

 

$541,504

 

$471,331

 

$2,009,833

 

$1,810,496

NET SALES - Ex-Precious Metals

 

489,193

 

421,290

 

1,819,899

 

1,623,074

 

 

 

 

 

 

 

 

 

COST OF PRODUCTS SOLD

 

268,773

 

230,521

 

969,050

 

881,485

 

 

 

 

 

 

 

 

 

GROSS PROFIT

 

272,731

 

240,810

 

1,040,783

 

929,011

% OF NET SALES

 

50.4%

 

51.1%

 

51.8%

 

51.3%

% OF NET SALES - Ex-Precious Metals

 

55.8%

 

57.2%

 

57.2%

 

57.2%

 

 

 

 

 

 

 

 

 

SELLING, GENERAL &

 

 

 

 

 

 

 

 

ADMINISTRATIVE EXPENSES

 

173,496

 

159,532

 

675,365

 

606,410

 

 

 

 

 

 

 

 

 

RESTRUCTURING AND OTHER

 

 

 

 

 

 

 

 

OPERATING COSTS

 

1,638

 

1,623

 

10,527

 

7,807

 

 

 

 

 

 

 

 

 

INCOME FROM OPERATIONS

 

97,597

 

79,655

 

354,891

 

314,794

% OF NET SALES

 

18.0%

 

16.9%

 

17.7%

 

17.4%

% OF NET SALES - Ex-Precious Metals

 

20.0%

 

18.9%

 

19.5%

 

19.4%

 

 

 

 

 

 

 

 

 

NET INTEREST AND OTHER NON-OPERATING

 

 

 

 

 

EXPENSE (INCOME)

 

399

 

578

 

(3,244)

 

(43)

 

 

 

 

 

 

 

 

 

PRE-TAX INCOME

 

97,198

 

79,077

 

358,135

 

314,837

 

 

 

 

 

 

 

 

 

INCOME TAXES

 

27,168

 

14,128

 

98,481

 

91,119

 

 

 

 

 

 

 

 

 

NET INCOME

 

70,030

 

64,949

 

259,654

 

223,718

% OF NET SALES

 

12.9%

 

13.8%

 

12.9%

 

12.4%

% OF NET SALES - Ex-Precious Metals

 

14.3%

 

15.4%

 

14.3%

 

13.8%

 

 

 

 

 

 

 

 

 

EARNINGS PER SHARE

 

 

 

 

 

 

 

 

-BASIC

 

$ 0.46

 

$ 0.43

 

$ 1.71

 

$ 1.44

-DILUTIVE

 

$ 0.45

 

$ 0.42

 

$ 1.68

 

$ 1.41

 

 

 

 

 

 

 

 

 

DIVIDENDS PER SHARE

 

$ 0.0450

 

$ 0.0400

 

$ 0.1650

 

$ 0.1450

 

 

 

 

 

 

 

 

 

WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING

 

 

 

 

 

 

 

 

-BASIC

 

151,173

 

152,211

 

151,707

 

155,229

-DILUTIVE

 

154,538

 

155,033

 

154,721

 

158,271

 

 

 

 

DENTSPLY INTERNATIONAL INC.

CONDENSED BALANCE SHEETS

(IN THOUSANDS)

 

 

 

 

 

 

 

 

 

 

 

 

DECEMBER 31,

 

DECEMBER 31,

 

 

2007

 

2006

 

 

 

 

 

ASSETS

 

 

 

 

 

 

 

 

 

CURRENT ASSETS:

 

 

 

 

 

 

 

 

 

CASH AND CASH EQUIVALENTS

 

          $ 169,384

 

            $ 65,064

SHORT TERM INVESTMENTS

 

146,939

 

79

ACCOUNTS AND NOTES RECEIVABLE-TRADE, NET

 

307,622

 

290,791

INVENTORIES, NET

 

258,032

 

232,441

OTHER CURRENT ASSETS

 

100,045

 

129,816

TOTAL CURRENT ASSETS

 

982,022

 

718,191

 

 

 

 

 

PROPERTY,PLANT AND EQUIPMENT, NET

 

371,409

 

329,616

IDENTIFIABLE INTANGIBLE ASSETS, NET

 

76,167

 

67,648

GOODWILL, NET

 

1,127,420

 

995,382

OTHER NONCURRENT ASSETS, NET

 

118,551

 

70,513

 

 

 

 

 

TOTAL ASSETS

 

       $ 2,675,569

 

       $ 2,181,350

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS' EQUITY:

 

 

 

 

 

 

 

 

 

CURRENT LIABILITIES

 

          $ 312,411

 

          $ 311,434

LONG-TERM DEBT

 

482,063

 

367,161

DEFERRED INCOME TAXES

 

60,547

 

53,191

OTHER LIABILITIES

 

304,146

 

175,507

TOTAL LIABILITIES

 

1,159,167

 

907,293

 

 

 

 

 

MINORITY INTEREST IN CONSOLIDATED SUBSIDIARIES

 

296

 

222

STOCKHOLDERS' EQUITY

 

1,516,106

 

1,273,835

 

 

 

 

 

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY

 

       $ 2,675,569

 

       $ 2,181,350

 

 

 

 

 

 

 

 

 

 

 

DENTSPLY INTERNATIONAL INC.

 

 

 

 

 

 

(IN THOUSANDS EXCEPT PER SHARE DATA)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating Income Summary:

 

 

 

 

 

 

 

 

 

 

The following tables present the reconciliation of reported GAAP operating income in total and on a percentage of net sales excluding precious metals basis to the non-GAAP financial measures.

 

 

 

 

 

 

Three Months Ended December 31, 2007

 

 

 

Percentage

 

 

 

 

 

of Net Sales

 

 

 

Operating Income

 

Ex-Precious

Metals

 

 

 

 

 

 

Income from Operations

 

   $ 97,597

 

20.0%

 

 

 

 

 

 

Restructuring, Impairment and Other Costs

 

1,638

 

0.3%

 

 

 

 

 

 

Adjusted Non-GAAP Operating Earnings

 

   $ 99,235

 

20.3%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended December 31, 2006

 

 

 

Percentage

 

 

 

 

 

of Net Sales

 

 

 

Operating Income

 

Ex-Precious

Metals

 

 

 

 

 

 

Income from Operations

 

   $ 79,655

 

18.9%

 

 

 

 

 

 

Restructuring, Impairment and Other Costs

 

1,623

 

0.4%

 

 

 

 

 

 

Adjusted Non-GAAP Operating Earnings

 

   $ 81,278

 

19.3%

 

 

 

 

 

 

 

 

 

 

 

 

DENTSPLY INTERNATIONAL INC.

 

 

 

 

 

 

(IN THOUSANDS EXCEPT PER SHARE DATA)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earnings Summary:

 

 

 

 

 

 

 

 

 

 

The following tables present the reconciliation of reported GAAP net income in total and on a per share basis to the non-GAAP financial measures.

 

 

 

 

 

 

Three Months Ended December 31, 2007

 

 

 

Adjusted

 

Diluted

 

 

 

Income

 

Per Share

 

 

 

 

 

 

Net Income

 

   $ 70,030

 

        $ 0.45

 

 

 

 

 

 

Restructuring, Impairment and

 

 

 

 

Other Costs, Net of Tax

 

965

 

0.01

 

 

 

 

 

 

Income Tax Related Adjustments

 

(2,493)

 

(0.02)

 

 

 

 

 

 

Adjusted Non-GAAP Earnings

 

   $ 68,502

 

        $ 0.44

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended December 31, 2006

 

 

 

Adjusted

 

Diluted

 

 

 

Income

 

Per Share

 

 

 

 

 

 

Net Income

 

   $ 64,949

 

        $ 0.42

 

 

 

 

 

 

Restructuring, Impairment and

 

 

 

 

Other Costs, Net of Tax

 

958

 

0.01

 

 

 

 

 

 

Income Tax Related Adjustments

 

(8,776)

 

(0.06)

 

 

 

 

 

 

Adjusted Non-GAAP Earnings

 

   $ 57,131

 

        $ 0.37

 

 

 

 

 

 

 

 

 

 

 

DENTSPLY INTERNATIONAL INC.

 

 

 

 

 

 

(IN THOUSANDS EXCEPT PER SHARE DATA)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating Income Summary:

 

 

 

 

 

 

 

 

 

 

The following tables present the reconciliation of reported GAAP operating income in total and on a percentage of net sales excluding precious metals basis to the non-GAAP financial measures.

 

 

 

 

 

 

Twelve Months Ended December 31, 2007

 

 

 

Percentage

 

 

 

 

 

of Net Sales

 

 

 

Operating Income

 

Ex-Precious

Metals

 

 

 

 

 

 

Income from Operations

 

 $ 354,891

 

19.5%

 

 

 

 

 

 

Restructuring, Impairment and Other Costs

 

10,527

 

0.6%

 

 

 

 

 

 

Adjusted Non-GAAP Operating Earnings

 

 $ 365,418

 

20.1%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Twelve Months Ended December 31, 2006

 

 

 

Percentage

 

 

 

 

 

of Net Sales

 

 

 

Operating Income

 

Ex-Precious

Metals

 

 

 

 

 

 

Income from Operations

 

 $ 314,794

 

19.4%

 

 

 

 

 

 

Restructuring, Impairment and Other Costs

 

7,807

 

0.5%

 

 

 

 

 

 

Adjusted Non-GAAP Operating Earnings

 

 $ 322,601

 

19.9%

 

 

 

 

 

 

 

 

 

 

 

 

DENTSPLY INTERNATIONAL INC.

 

 

 

 

 

 

(IN THOUSANDS EXCEPT PER SHARE DATA)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earnings Summary:

 

 

 

 

 

 

 

 

 

 

The following tables present the reconciliation of reported GAAP net income in total and on a per share basis to the non-GAAP financial measures.

 

 

 

 

 

 

Twelve Months Ended December 31, 2007

 

 

 

 

 

Adjusted

 

Diluted

 

 

 

Income

 

Per Share

 

 

 

 

 

 

Net Income

 

   $ 259,654

 

            $ 1.68

 

 

 

 

 

 

Restructuring, Impairment and

 

 

 

 

Other Costs, Net of Tax

 

6,675

 

0.04

 

 

 

 

 

 

Income Tax Related Adjustments

 

(9,893)

 

(0.06)

 

 

 

 

 

 

Adjusted Non-GAAP Earnings

 

   $ 256,436

 

            $ 1.66

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Twelve Months Ended December 31, 2006

 

 

 

 

 

Adjusted

 

Diluted

 

 

 

Income

 

Per Share

 

 

 

 

 

 

Net Income

 

    $ 223,718

 

            $ 1.41

 

 

 

 

 

 

Restructuring, Impairment and

 

 

 

 

Other Costs, Net of Tax

 

5,017

 

0.03

 

 

 

 

 

 

Income Tax Related Adjustments

 

(4,765)

 

(0.03)

 

 

 

 

 

 

Rounding

 

 

 

0.01

 

 

 

 

 

 

Adjusted Non-GAAP Earnings

 

   $ 223,970

 

            $ 1.42